Application: 4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene (CAS #461432-23-5 ) is a hydrocarbon derivative, which can be used as a reagent in the synthesis of Dapagliflozin (D185370); a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
Huateng Pharma can provide dapagliflozin intermediates (CAS# 461432-23-5) from lab to commercial scale. We can also provide CDMO services with sufficient capacity. Contact us at firstname.lastname@example.org now.
I want to comment